5 unknown. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Unknown 5 |
Follow Pneumococcal Infections: new trials by email Literature Review of Pneumococcal Infections trials Research Report on Pneumococcal Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I Study of XJ103 in Chinese Healthy Subjects XJ103 Injection, Placebo - Pneumococcal Disease | Phase 1 | Unknown | Starmab biologics（Shanghai）Co,.ltd | 38 | 2023-09-12 | 2024-03-27 |
| A Study to Evaluate Tolerability, Safety and Immunogenicity of MVX01 Pneumococcal Vaccine MVX01, MVX01 Placebo - Pneumococcal Vaccine | Phase 1 | Unknown | Matrivax Research and Development Corporation | 75 | 2023-03-07 | 2024-03-29 |
| Phase I Clinical Trial of a Candidate PCV13 in Healthy People 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine - Pneumococcal Infections | Phase 1 | Unknown | Wuhan BravoVax Co., Ltd. | 264 | 2022-11-01 | 2022-11-17 |
| Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in Healthy Volunteers Aged Above 2 Months 15-Valent Pneumococcal Conjugate Vaccine - Pneumonia, Pneumococcal | Phase 1 | Unknown | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 80 | 2019-06-05 | 2019-09-30 |
| A Study to Evaluate the Safety and Immunogeneicity of Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults LBVE01, LBVE02, Prevnar13 - Pneumococcal Infection | Phase 1 | Unknown | LG Chem | 60 | 2018-07-01 | 2018-06-13 |
Pneumonia, Pneumococcal (2) · Pneumonia (1) · Pneumonia, Bacterial (1)
Bacterial Infections (5) · Bacterial Infections and Mycoses (5) · Gram-Positive Bacterial Infections (5) · Infections (5) · Streptococcal Infections (5) · Lung Diseases (3) · Respiratory Tract Diseases (3) · Respiratory Tract Infections (3) · Pneumonia (2) · Pneumonia, Bacterial (2)
13-valent pneumococcal vaccine (1)
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd (1) · LG Chem (1) · Matrivax Research and Development Corporation (1) · Starmab biologics（Shanghai）Co,.ltd (1) · Wuhan BravoVax Co., Ltd. (1)
China (3) · United States (1)
Du Lin, Master (1) · Myoung-don Oh, M.D. (1)